NADPH oxidase-IN-1, CAS [[2762405-17-2]]

Produktübersicht

• Artikelname: NADPH oxidase-IN-1, CAS [[2762405-17-2]]
• Artikelnummer: MCE-HY-152026
• Hersteller Artikelnummer: HY-152026
• Alternativnummer: MCE-HY-152026-50MG,MCE-HY-152026-25MG,MCE-HY-152026-100MG,MCE-HY-152026-5MG,MCE-HY-152026-10MMX1ML,MCE-HY-152026-10MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien

Produktbeschreibung

NADPH oxidase-IN-1 is an orally active NADPH oxidase (Nox) inhibitor, related with neuronal inflammation. NADPH oxidase-IN-1 can cross the blood-brain barrier (BBB), inhibits Nox2 and Nox4 with IC50s of 1.9 µM and 2.47 µM, respectively. NADPH oxidase-IN-1 suppresses pro-inflammatory cytokines production and LPS-mediated microglial migration, also has in vivo efficacy[1].

Produkteigenschaften

• Molekulargewicht: 373.51
• Reinheit: 99.69
• CAS Nummer: [2762405-17-2]
• Formel: C20H27N3O2S
• Target-Kategorie: NADPH Oxidase

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound